Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Total Debt (2016 - 2026)

Phibro Animal Health has reported Total Debt over the past 13 years, most recently at $127.6 million for Q4 2025.

  • For Q4 2025, Total Debt fell 2.01% year-over-year to $127.6 million; the TTM value through Dec 2025 reached $127.6 million, down 2.01%, while the annual FY2025 figure was $631.7 million, 102.41% up from the prior year.
  • Total Debt for Q4 2025 was $127.6 million at Phibro Animal Health, down from $628.0 million in the prior quarter.
  • Over five years, Total Debt peaked at $635.4 million in Q1 2025 and troughed at $104.4 million in Q2 2021.
  • A 5-year average of $292.3 million and a median of $288.4 million in 2021 define the central range for Total Debt.
  • Biggest five-year swings in Total Debt: plummeted 59.79% in 2024 and later surged 236.71% in 2025.
  • Year by year, Total Debt stood at $120.1 million in 2021, then surged by 66.01% to $199.4 million in 2022, then surged by 62.42% to $323.9 million in 2023, then plummeted by 59.79% to $130.2 million in 2024, then decreased by 2.01% to $127.6 million in 2025.
  • Business Quant data shows Total Debt for PAHC at $127.6 million in Q4 2025, $628.0 million in Q3 2025, and $631.7 million in Q2 2025.